News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

Endometrial Cancer Biocryst (BCRX) Multiple Myeloma Sanofi (SNY) KITE (KITE) Sequenom (SQNM) OSI (OSIP) ISIS (ISIS) ACADIA (ACAD) Tysabri Ocular Therapeutix (OCUL) Cytokinetics (CYTK) Intrexon (XON) ARGOS (ARGS) PTC Therapeutics (PTCT) Velcade (bortezomib) TOKAI (TKAOI) Idenix (IDIX) Anacor (ANAC) NEKTAR (NKTR)) Roche (ROCHE) Jazz Pharmaceuticals (JAZZ) Abbott Laboratories (ABT) Global Cell Therapeutics (GBT) Amgen (AMGN) Agenus (AGEN Human Genome Sciences (HGSI) NEUROCRINE (NBIX) NANTKWEST (NK) INNOVIVA (INVA) ZALTRAP™ Inovio (INO) Mirati Therapeutics (MRTX) Agenus (AGEN) Auspex (ASPX) Advaxis (ADXS) Valeant Pharmaceuticals International (VRX) Dendreon (DNDN) SYNTA (SNTA) Trastuzumab-DM1 Exelixis (EXEL) Elan (ELN) Sanofi-Aventis (SAN) Incyte (INCY) Vitae Pharmaceuticals (VTAE) Vertex (VRTX) Ziofpharm (ZIOP) AERIE PHARMACEUTICALS Regeneron (REGN) Seattle Genetics (SGEN) Roche (RHHBY) ADVENTRIX (ANX) Xoma (XOMA) Illumina (ILMN) JUNO (JUNO) IDERA (IDRA) SERES THERAPEUTICS (MCRB) Prolor Biotech (PBTH) Spike Therapeutics (ONCE) Merck (MRK) Biogen Idec (BIIB) KERYX (KERX) Herceptin SUNESIS PHARMACEUTICALS (SNSS) Gilead (GILD) Intermune (ITMN) Ionis (IONS) ImmunoGen (IMGN) Galena (GALE) Onyx (ONXX) Theravance Bio Pharma (TBPH) GlaxoSmithKline (GSK) Revlimid (lenolidamide) NOVOCURE (NVCR) AGOS (ARGS) Telaprevir Theravance (THRX) CompuGen (CGEN) Pluristem (PSTI) LEXICON (LXRX) Bellicum (BLCM) Genentech PORTOLA (PTLA) Bristol-Myers Squibb (BMY) Array Pharmaceuticals (ARRY) Sangamo (SGMO) OncoCyte (OCX) ARCA (ABIO) RenenxBio (RGNX) Sanofi (SNA) Alder Biopharmaceuticals (ALDR) Ariad (ARIA) CRISPR Therapeutics (CRSP) VANDA (VNDA) Alnylam (ALNY) Intercept (ICPT) C4 Therapeutics Ridaforolimus REGULUS (RGLS) Human Longevity (HLI) MODERNA galapagos (GLPG) ABBVIE (ABBV) Prosensa (RNA) HALOZYME (HALO) Sarepta (SRPT) Editas (EDIT) GUARDIAN HEALTH Aimmune Therapeutics (AIMT) AstraZeneca (AZN) Zerenex Anadys (ANDS) JOUNCE THERAPEUTICS (JNCE) Rapamune Dynavax (DVAX) Benlysta (belimumab) Micromet (MITI) BIOMARIN (BMRN) Adaptimmune (ADAP) CEMPRA (CEMP)